期刊文献+

遵循“规范”踏实前进不断提高我国产前诊断水平 被引量:2

Making progress based on standards to improve the level of prenatal diagnosis in China
原文传递
导出
摘要 产前诊断是预防出生缺陷的重要措施,经过数十年的不懈努力与探索实践,我国产前诊断在网络建设、技术进步和普及以及服务能力等方面均取得很大的进步。从最初零星分散的产前诊断科室,发展到目前全国大部分地区初步形成的产前筛查一产前诊断一干预和出生缺陷监测工作的三级网络;从最初的唐氏综合征产前筛查与诊断技术,发展为更宽范围的胎儿遗传物质异常及形态学异常的产前诊断技术体系。
作者 胡娅莉 李洁
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2015年第9期785-787,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 产前诊断 产前筛查 遗传学 prenatal diagnosis prenatal screening genetics
  • 相关文献

参考文献21

  • 1中华人民共和国卫生部.中国出生缺陷防治报告(2012)[R].北京:中华人民共和国卫生部,2012,3.
  • 2Game E,Loane M,Dolk H.Prenatal diagnosis of severe structural congenital malformations in Europe [J].Uhrasound Obstet Gyne- col,2005, 25: 6-11.
  • 3Chaoui R.The four- chumber view: four reasons why it seems to fail in screening for cardiac abnormalities and suggestions to im- prove detection rate [J].Uhrosound Obstet Gynecol, 2003, 22: 3- 10.
  • 4Ozcan UA, Iik U, Dincer A, et al. Identification of fetal precen- tral gyms on diffusion weighted MRI[J].Brain Dev, 2013,35:4-9.
  • 5Ronald JW, Christa LM, Brynn L, et al.Chromosoma] microarray versus karyotyping for prenatal diagnosis [ J ].N Engl, 2012,367 (23) :2175-2184.
  • 6Saldarriaga W, Garclia-Perdomo HA, Arango-Pineda J, et al. Karyotype versus genomic hybridization for the prenatal diagno- sis of chromosomal abnormalities: a recta-analysis [J ].Am J Ob- stet Gynecol, 2015,212:330.e 1-10.
  • 7American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion No. 581: the use of chromosom-al microarray analysis in prenatal diagnosis [J].Obstet Gynecol, 2013, 122:1374.
  • 8Kearney HM,South ST,Wolff DJ,et al.American College of Medi- cal Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays in- tended for use in the postnatal setting for detection of constitu- tional abnormalities [ J ].Genet Med,2011,13:676-679.
  • 9染色体微阵列分析技术在产前诊断中的应用专家共识[J].中华妇产科杂志,2014,49(8):570-572. 被引量:249
  • 10Howard C,Peter B, Eugene P. Maternal cfDNA screening for Down syndrome- a cost sensitivity analysis [J].Prenatal Di- agn, 2013,33:636-642.

二级参考文献7

  • 1Brady PD, Vermeesch JR. Genomic microarrays: a technology overview[J]. Prenat Diagn, 2012,32:336-343.
  • 2Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010,86: 749-764.
  • 3Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2013,41:610-620.
  • 4Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarray-based comparative genomie hybridization for prental diagnosis in over 5000 pregnancies[J]. Prenat Diagn, 2012,32: 976-985.
  • 5Shaffer LG, Dosenfeld JA, Dabell MP, et al. Detection rates of clinically significant genomie alterations by mieroarray analysis for specific anomalies detected by ultrasound[J]. Prenat Diagn, 2012,32:986-995.
  • 6Wapner R J, Marthin CL, Lery B, et al. Chromosomal microarray versus karyotyping for prental diagnosis[J]. N Engl J Med, 2012, 367:2175-2184.
  • 7American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis[J]. Obstet Gynecol,2013,122:1374-1377.

共引文献277

同被引文献21

引证文献2

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部